BioNexus Gene Lab Corp. (BGLC) vs Decent Holding Inc. (DXST)
A side-by-side comparison of BioNexus Gene Lab Corp. and Decent Holding Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.28IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT
DXST
Decent Holding Inc.
$2.12IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BGLC vs DXST
growth of $100 · dividends reinvested · last 2yBGLC -64.2% (-40.2%/yr)DXST -97.9% (-85.5%/yr)BGLC compounded faster over this window
Log scale — wide-divergence pair
BGLC DXST
BGLC vs DXST: by the numbers
- •BGLC is the larger company ($3M vs $1M market cap).
- •Both run net losses; DXST's is the smaller (-3.51% vs -82.36% net margin).
Metrics side by side
Valuation
| Metric | BGLC | DXST |
|---|---|---|
| P/S ratio | 0.99 | 0.04 |
| P/B ratio | 0.40 | 0.10 |
Profitability
| Metric | BGLC | DXST |
|---|---|---|
| Gross margin | 11.64% | 31.10% |
| Operating margin | -42.54% | -2.11% |
| Net margin | -82.36% | -3.51% |
| ROE | -33.11% | -9.84% |
| ROIC | -32.71% | -5.61% |
Growth (annualized)
| Metric | BGLC | DXST |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | N/A |
| Total return CAGR (5Y) | -61.00% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.